발행물
컨퍼런스
2013 한국실험동물학회 국제학술대회
,
A progression of breast cancer appears to be inhibited by the treatment with a putative estrogenic agent, triclosan, via upregulation of cyclin D and cathepsin in female nude mice
An interaction of estrogen receptor and insulin-like growth factor 1 receptor signaling pathways is involved in the anticancer effect of genistein on ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk
Chemo- and immune-therapies using engineered stem cells via upregulation of type I interferon alpha/beta receptor and BAX genes in a ductal breast cancer mouse model
Treatment with octylphenol can lead to stimulate breast cancer cell growth via the alterations of cyclin D1 and p21 genes in human breast cancer cells through an estrogen receptor-mediated signaling pathway in breast cancer xenografted mice
Transforming growth factor-beta signaling pathway was suppressed in the tumor progression caused by 4-nonylphenol and bisphenol A in BG-1 ovarian cancer xenografted mice